Form 4: Enovix Director Bernard Gutmann Receives RSU Grant

Director Bernard Gutmann acquired 29,104 restricted stock units in Enovix Corporation as part of a standard equity compensation grant.

Summary

• Director Bernard Gutmann was granted 29,104 restricted stock units (RSUs) on June 11, 2026.
• Each RSU represents a contingent right to receive one share of Enovix common stock.
• The grant is subject to a vesting schedule spanning from September 2026 through June 2027.
• Following this transaction, the director's total beneficial ownership increased to 99,063 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative filing regarding director compensation, which has no material impact on the company's financial outlook.

Positives

• The grant aligns the director's interests with long-term shareholder value through equity-based compensation.

Negatives

• None identified; this is a routine equity compensation disclosure.

Risks

• Vesting is contingent upon the director's continuous service to the company through each applicable date.

Future Outlook

The RSUs are scheduled to vest in four equal quarterly installments, contingent upon continued service as a director.

Industry Context

StockSavvy.ai notes that this filing represents standard corporate governance practice for technology companies, where directors are compensated with equity to ensure alignment with shareholder interests.

Comparison to Industry Standards

• The use of RSU grants for board compensation is consistent with standard practices for NASDAQ-listed technology firms.
• The vesting schedule is typical for director equity awards, ensuring retention over a one-year period.

Corporate Governance

Stakeholder Impact

• Shareholders: Minimal impact; reflects standard director compensation practices.

Next Steps

• Vesting of the first tranche of RSUs on September 11, 2026.

Key Dates

Keywords

Enovix, ENVX, Form 4, Insider Trading, Director Compensation, Equity Grant